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Mutations in the BRCA1 and BRCA2 genes predispose
women to breast and ovarian cancer. The large majority
of the alterations identified in these genes are point
mutations and small insertion/deletion. However, an
increasing number of large genomic rearrangements are
being identified, especially in BRCA1. To date 161 and
39 gene alterations have been described in the literature,
approximately for BRCA1 and BRCA2. Just few large
genomic rearrangements of BRCA1 gene have been
reported in Poland.
Technical limitations of conventional PCR-based
methods are cause that gross rearrangements can be
overlooked. It has been suggest that about 30% of muta-
tions in the BRCA1 gene are missed by standard muta-
tion detection methods. We use Multiplex Ligation-
dependent Probe Amplification (MLPA) to analyze
BRCA1/2 rearrangements in 300 unrelated patients with
strong family history of breast and/or ovarian cancer
negative for BRCA1 Polish founder mutation.
The purpose of this study is establish the prevalence
of BRCA1 and BRCA2 large genomic rearrangements in
patients with hereditary breast and/or ovarian cancer of
Polish population.
Published: 12 January 2012
doi:10.1186/1897-4287-10-S1-A1
Cite this article as: Bielecka and Górski: Large genomic rearrangements
in BRCA1 and BRCA2 genes in breast and ovarian cancer families in
Poland. Hereditary Cancer in Clinical Practice 2012 10(Suppl 1):A1.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit International Hereditary Cancer Center, Department of Genetics and
Pathology, Pomeranian Medical University, Szczecin, Poland
Bielecka and Górski Hereditary Cancer in Clinical Practice 2012, 10(Suppl 1):A1
http://www.hccpjournal.com/content/10/S1/A1
© 2012 Bielecka and Górski; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.